Inventor · disambiguated record
Werner Hoellriegl
Also filed as: HOELLRIEGL WERNER
2 granted patents·4 pending applications·0 citations·filing 2019–2024
30Inventor score
Top patents by PatentIndex Score
6 records- 0172US11779635B2Subcutaneous administration of ADAMTS13TAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Oct 10, 2023·0 cites·17 claims
- 0270US2025043310A1Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0359US2024390517A1Aav8 capsid variants with enhanced liver targetingTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0455US12091675B2Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·8 claims
- 0546US2023023826A1Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 0640US2022249628A1Use of recombinant adamts13 for treating sickle cell diseaseTAKEDA PHARMACEUTICAL COMPANY LIMIED·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Werner Hoellriegl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →